Learn about cost, uses, and more of Keytruda (pembrolizumab). It's a prescription drug that treats certain cancers in adults and some children.

Trodelvy, in combination with Merck’s immunotherapy Keytruda, lowered the risk of an aggressive type of breast cancer worsening by 35% when used as an initial treatment, according to new resu… ...

Keytruda treats many types of cancer and can cause side effects, some of which may be long term. Learn about side effects and how to manage them.

Trodelvy when given in combination with Keytruda resulted in a median progression-free survival (PFS) of 11.2 months. FOSTER CITY, Calif., May 31, 2025--Gilead Sciences, Inc. ...

RAHWAY, N.J., May 31, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that KEYTRUDA® (pembrolizumab) plus Trodelvy® (sacituzumab govitecan-hziy ...

The US Food and Drug Administration (FDA) has approved MSD’s KEYTRUDA regimen as a first-line treatment for adults with unresectable advanced or metastatic malignant pleural mesothelioma (MPM ...

Keytruda is a prescription drug used to treat certain types of cancer. Learn more about how to know whether Keytruda is working and more.

Continuous use of Keytruda—both before and after surgery—reduced the risk of recurrence or death by 27% in patients with stage 3 or 4a, resected, locally advanced head and neck squamous cell ...

They urged Vidal to "give close scrutiny to any of Merck’s requests for new patents for Keytruda, and reject those that do not clearly meet the agency’s standards." ...